3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Skin Neoplasms
1
Rectal Diseases
1
Pilonidal Sinus
1
Pancreatic Neoplasms
1
Pain, Postoperative
1
Hemorrhage
1
Endometriosis
1
Dysplastic Nevus Syndrome
1
Diverticulitis
1
Crohn Disease
1
Constipation
1
Colonic Diseases
1
Colitis, Ulcerative
1
Carcinoma, Squamous Cell
1
Carcinoma, Basal Cell
1
Bile Duct Neoplasms
1
Interventions
Nivolumab
74
Sunitinib
73
pembrolizumab
49
Everolimus
39
Sorafenib
36
Bevacizumab
36
Axitinib
36
cabozantinib
35
Radiosurgery
33
Ipilimumab
33
pazopanib
32
Magnetic Resonance Spectroscopy
27
Interleukin-2
27
aldesleukin
23
Specimen Handling
22
Cyclophosphamide
21
lenvatinib
20
fludarabine phosphate
17
Radiotherapy
16
Interferon-alpha
15
Peripheral Blood Stem Cell Transplantation
14
Gemcitabine
14
Biopsy
14
temsirolimus
13
Nephrectomy
13
durvalumab
11
Immunohistochemistry
11
CTLA-4 Antigen
11
Blood Specimen Collection
11
Capecitabine
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Renal Cell
×
Sutures
×
Clear all
NCT07232927
2025-11-18
HEMOSTA-PN
Ankara University
Phase NA
Completed
150 enrolled
NCT07190638
2025-09-24
CORTEX
Brazilian Institute of Robotic Surgery
Phase NA
Recruiting
80 enrolled